GEn-1123
/ GEn1E Lifesci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 09, 2026
GEn1E Lifesciences Inc…announced that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) to GEn-1123 for the treatment of Duchenne Muscular Dystrophy (DMD).
(Businesswire)
FDA event • Orphan drug • Duchenne Muscular Dystrophy
1 to 1
Of
1
Go to page
1